G20, India, and the Multi-Billion-Dollar Prevention Opportunity: How WHIS is Unlocking Health and Economic Growth
India’s G20 Presidency, anchored by the theme of “Vasudhaiva Kutumbakam” or “One Earth - One Family - One Future”, set a powerful global agenda, prioritizing health, inclusive growth, and climate change. At the heart of this vision lies a monumental economic opportunity: transforming global health systems through upstream prevention, a shift the World Health Innovation Summit (WHIS) is actively championing in India. Reframing Health as an Economic Catalyst.
The case for health reform is urgent and overwhelmingly economic. The current global health system is an estimated $12 trillion industry, yet approximately 97% of this staggering sum is dedicated to treatment, leaving only around 3% for prevention. This reactive, sick-care model is financially unsustainable.
The G20 is being called upon to reframe health not as a cost, but as an intentional investment priority. The potential return on investment (ROI) is transformative: prevention can deliver up to a $24 return for every $1 invested. To seize this economic opportunity, the WHIS G20 position calls for a deliberate shift to rebalance public investment toward a 50/50 split between treatment and prevention over the next decade. India, which is embracing its “Amrit Kaal” a period of strategic opportunity is an ideal global exemplar for this reform. India’s G20 priority on accelerated, inclusive, and resilient growth is perfectly aligned with the economic uplift created by preventative health. Furthermore, investing in the care economy could create 300 million new jobs globally, a crucial factor for a nation focused on addressing the global skills gap and fostering structural transformation.
WHIS and the India Momentum WHIS and the Global Social Prescribing Alliance(GSPA) provide the innovative framework needed to deliver this systemic change and secure foreign direct investment (FDI) into the Indian market. WHIS is acting as the “springboard” and “innovation driver”for new models by:
- Scaling Proven Models: The G20 position paper advocates for scaling proven place-based models like WHIS Cities and championing Social Prescribing (GSPA). These models are validated by evidence: early modeling indicates they can deliver up to £4 in social and economic value per £1 invested, with Social Prescribing proven to reduce GP visits by 42% and A&E attendance by up to 23% in national evaluations.
- Leveraging Indian Exemplars: The G20 position paper will specifically recommend recognizing and leveraging exemplary policies and lessons ratified in India for scaling innovative healthcare technologies internationally.
- Driving Innovation and Investment: The vision for WHIS India is to establish Delhi as the Innovation Capital of Asia through a multi-year commitment (anticipated 2026–2028). By aligning its G20 focus with the measurable, scalable investment model of prevention championed by WHIS India. India has the opportunity to lead the world in building a resilient global health system, creating millions of meaningful jobs, and achieving accelerated, inclusive, and decisive economic growth.